| Activating STAT6 mutations in follicular lymphoma M Yildiz, H Li, D Bernard, NA Amin, P Ouillette, S Jones, K Saiya-Cork, ... Blood, The Journal of the American Society of Hematology 125 (4), 668-679, 2015 | 178 | 2015 |
| Clonal evolution and devolution after chemotherapy in adult acute myelogenous leukemia B Parkin, P Ouillette, Y Li, J Keller, C Lam, D Roulston, C Li, K Shedden, ... Blood 121 (2), 369-377, 2013 | 145 | 2013 |
| Multiple distinct molecular mechanisms influence sensitivity and resistance to MDM2 inhibitors in adult acute myelogenous leukemia J Long, B Parkin, P Ouillette, D Bixby, K Shedden, H Erba, S Wang, ... Blood, The Journal of the American Society of Hematology 116 (1), 71-80, 2010 | 99 | 2010 |
| α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease JM Magenau, SC Goldstein, D Peltier, RJ Soiffer, T Braun, A Pawarode, ... Blood, The Journal of the American Society of Hematology 131 (12), 1372-1379, 2018 | 98 | 2018 |
| Aggressive chronic lymphocytic leukemia with elevated genomic complexity is associated with multiple gene defects in the response to DNA double-strand breaks P Ouillette, S Fossum, B Parkin, L Ding, P Bockenstedt, A Al-Zoubi, ... Clinical Cancer Research 16 (3), 835-847, 2010 | 90 | 2010 |
| Acquired genomic copy number aberrations and survival in adult acute myelogenous leukemia B Parkin, H Erba, P Ouillette, D Roulston, A Purkayastha, J Karp, ... Blood, The Journal of the American Society of Hematology 116 (23), 4958-4967, 2010 | 78 | 2010 |
| NF1 inactivation in adult acute myelogenous leukemia B Parkin, P Ouillette, Y Wang, Y Liu, W Wright, D Roulston, A Purkayastha, ... Clinical Cancer Research 16 (16), 4135-4147, 2010 | 77 | 2010 |
| A quantitative analysis of subclonal and clonal gene mutations before and after therapy in chronic lymphocytic leukemia NA Amin, E Seymour, K Saiya-Cork, B Parkin, K Shedden, SN Malek Clinical Cancer Research 22 (17), 4525-4535, 2016 | 73 | 2016 |
| Vorinostat plus tacrolimus/methotrexate to prevent GVHD after myeloablative conditioning, unrelated donor HCT SW Choi, T Braun, I Henig, E Gatza, J Magenau, B Parkin, A Pawarode, ... Blood, The Journal of the American Society of Hematology 130 (15), 1760-1767, 2017 | 60 | 2017 |
| Ultrasensitive mutation detection identifies rare residual cells causing acute myelogenous leukemia relapse B Parkin, A Londoño-Joshi, Q Kang, M Tewari, AD Rhim, SN Malek The Journal of Clinical Investigation 127 (9), 3484-3495, 2017 | 49 | 2017 |
| Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner S He, B Malik, D Borkin, H Miao, S Shukla, K Kempinska, T Purohit, ... Leukemia 30 (2), 508-513, 2016 | 47 | 2016 |
| FLT3 mutational status is an independent risk factor for adverse outcomes after allogeneic transplantation in AML Y Song, J Magenau, Y Li, T Braun, L Chang, D Bixby, DA Hanauer, ... Bone marrow transplantation 51 (4), 511-520, 2016 | 46 | 2016 |
| A pathobiological role of the insulin receptor in chronic lymphocytic leukemia K Saiya-Cork, R Collins, B Parkin, P Ouillette, E Kuizon, L Kujawski, ... Clinical Cancer Research 17 (9), 2679-2692, 2011 | 42 | 2011 |
| Integrated genomic profiling, therapy response, and survival in adult acute myelogenous leukemia B Parkin, P Ouillette, M Yildiz, K Saiya-Cork, K Shedden, SN Malek Clinical Cancer Research 21 (9), 2045-2056, 2015 | 30 | 2015 |
| Therapeutic targeting of TP53-mutated acute myeloid leukemia by inhibiting HIF-1α with echinomycin Y Wang, Y Liu, C Bailey, H Zhang, M He, D Sun, P Zhang, B Parkin, ... Oncogene 39 (14), 3015-3027, 2020 | 29 | 2020 |
| A phase 2 study of pembrolizumab during lymphodepletion after autologous hematopoietic cell transplantation for multiple myeloma A D'Souza, P Hari, M Pasquini, T Braun, B Johnson, S Lundy, D Couriel, ... Biology of Blood and Marrow Transplantation 25 (8), 1492-1497, 2019 | 29 | 2019 |
| Maintenance sorafenib in FLT3-ITD AML following allogeneic HCT favorably impacts relapse and overall survival G Chappell, M Geer, E Gatza, T Braun, T Churay, J Brisson, D Bixby, ... Bone Marrow Transplantation 54 (9), 1518-1520, 2019 | 23 | 2019 |
| A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic … J Magenau, P Westervelt, S Khaled, J McGuirk, P Hari, M Eapen, ... Bone marrow transplantation 52 (1), 59-65, 2017 | 22 | 2017 |
| The rocky road to personalized medicine in acute myeloid leukaemia B Brinda, I Khan, B Parkin, H Konig Journal of cellular and molecular medicine 22 (3), 1411-1427, 2018 | 21 | 2018 |
| Type 1 interferon to prevent leukemia relapse after allogeneic transplantation JM Magenau, D Peltier, M Riwes, A Pawarode, B Parkin, T Braun, ... Blood advances 5 (23), 5047-5056, 2021 | 15 | 2021 |
